Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Astrocytoma, Grade IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT04555577
What this trial is testing

Phase I Trial of DNA-PK Inhibitor (PEPOSERTIB ) in Combination With Radiation and Adjuvant Temozolomide in Newly Diagnosed MGMT Unmethylated and Recurrent Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
M.D. Anderson Cancer Center 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT03405792
What this trial is testing

Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)

Who this might be right for
GlioblastomaGlioblastoma, WHO Grade IV
University of Florida 40
Early research (Phase 1)Study completedNCT03452930
What this trial is testing

Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma

Who this might be right for
GlioblastomaGliosarcomaMGMT-Unmethylated Glioblastoma
M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT00869401
What this trial is testing

Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 217
Testing effectiveness (Phase 2)WithdrawnNCT00006263
What this trial is testing

Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
NYU Langone Health
Testing effectiveness (Phase 2)Active Not RecruitingNCT03197506
What this trial is testing

Pembrolizumab and Standard Therapy in Treating Patients With Glioblastoma

Who this might be right for
GlioblastomaGliosarcomaSupratentorial Glioblastoma
Mayo Clinic 52
Testing effectiveness (Phase 2)UnknownNCT00394628
What this trial is testing

AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Novacea 60
Not applicableStudy completedNCT00253487
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Younger Patients Who Are Undergoing an Autologous Stem Cell Transplant for Newly Diagnosed Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Children's Hospital Medical Center, Cincinnati
Not applicableEnded earlyNCT00756106
What this trial is testing

MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Massachusetts General Hospital 15
Testing effectiveness (Phase 2)Study completedNCT02715609
What this trial is testing

Disulfiram/Copper With Concurrent Radiation Therapy and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Washington University School of Medicine 35
Early research (Phase 1)UnknownNCT00768911
What this trial is testing

CT-322 in Combination With Radiation Therapy and Temozolomide to Treat Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Adnexus, A Bristol-Myers Squibb R&D Company 30
Testing effectiveness (Phase 2)Study completedNCT00022256
What this trial is testing

Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00014170
What this trial is testing

Gefitinib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 92
Testing effectiveness (Phase 2)UnknownNCT02772094
What this trial is testing

Dendritic Cell-Based Tumor Vaccine Adjuvant Immunotherapy of Human Glioblastoma Multiforme (WHO Grade IV Gliomas)

Who this might be right for
Glioblastoma MultiformeGlioblastoma
China Medical University Hospital 50
Not applicableStudy completedNCT01478854
What this trial is testing

Neural Progenitor Cell Sparing Radiation Therapy Plus Temozolomide

Who this might be right for
Glioblastoma Multiforme
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 33
Testing effectiveness (Phase 2)Study completedNCT00004073
What this trial is testing

Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 54
Testing effectiveness (Phase 2)Looking for participantsNCT06805305
What this trial is testing

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

Who this might be right for
Glioblastoma (GBM)
Diakonos Oncology Corporation 180
Testing effectiveness (Phase 2)Study completedNCT00004017
What this trial is testing

Radiolabeled Monoclonal Antibody in Treating Patients With Glioblastoma Multiforme or Anaplastic Astrocytoma

Who this might be right for
Brain and Central Nervous System Tumors
Peregrine Pharmaceuticals 60
Not applicableStudy completedNCT02379572
What this trial is testing

Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas

Who this might be right for
Glioblastoma
University Hospital Tuebingen 315
Not applicableActive Not RecruitingNCT03297125
What this trial is testing

Assessment of Optune Therapy for Patients With Newly Diagnosed Glioblastoma Using Advanced MRI

Who this might be right for
Glioblastoma
Medical College of Wisconsin 60
Next Page